Within the CNS WHO grade 3 meningioma cohort, the OS (Figure 1A; P < .01) and LPFS (Figure 1B; P < .05) of patients with EZH2-high tumors were significantly shorter compared to the EZH2-low group. This evidence concerns the gene EZH2 and meningioma.